Concepedia

Zhongling Zhu

ZZ

6

Publications

290

Citations

6

H-Index

2013

Active since

Affiliations

Tianjin Medical University Cancer Institute and Hospital(Current)

Zhongling Zhu is an author at Tianjin Medical University Cancer Institute and Hospital specializing in cell biology, medicine, and tumor microenvironment.

ORCID

Top concepts

Publications per year

2013–2021

6

Publications

6

Glutathione reductase mediates drug resistance in glioblastoma cells by regulating redox homeostasis

Zhongling Zhu, Shuangshuang Du, Yibo Du et al. · Journal of Neurochemistry · 2017 · 165 citations · Full text

, , +17

BHX, a novel pyrazoline derivative, inhibits breast cancer cell invasion by reversing the epithelial-mesenchymal transition and down-regulating Wnt/β-catenin signalling

Hanmei Bao, Qing Zhang, Zhongling Zhu et al. · Scientific Reports · 2017 · 32 citations · Full text

Ursolic acid attenuates temozolomide resistance in glioblastoma cells by downregulating O(6)-methylguanine-DNA methyltransferase (MGMT) expression.

Zhongling Zhu, Shuangshuang Du, Fengxia Ding et al. · PubMed · 2016 · 31 citations

, , +19

Silk fibroin peptide suppresses proliferation and induces apoptosis and cell cycle arrest in human lung cancer cells

Meisa Wang, Yibo Du, Huiming Huang et al. · Acta Pharmacologica Sinica · 2018 · 29 citations · Full text

, , +14

Synthesis, characterization, and evaluation of a novel inhibitor of WNT/β-catenin signaling pathway

Zhao Yan, Zhongling Zhu, Jinghui Wang et al. · Molecular Cancer · 2013 · 17 citations · Full text

Rows per page

1–5 of 6